Evidence map›Paper›PMID 30587816›Full record

ArticleInternational journal of molecular sciences2018

Oxytocin Administration Alleviates Acute but Not Chronic Leptin Resistance of Diet-Induced Obese Mice.

Mehdi Labyb, Chloé Chrétien, Aurélie Caillon, Françoise Rohner-Jeanrenaud, Jordi Altirriba

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Oxytocin as an Anti-obesity Treatment.Frontiers in neuroscience · 2021
    Review
  11. Article
  12. There and Back Again: Leptin Actions in White Adipose Tissue.International journal of molecular sciences · 2020
    Review
  13. Review
  14. Incendiary Leptin.Nutrients · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mehdi LabybLaboratory of Metabolism, Department of Medicine Specialties, Faculty of Medicine, University of Geneva, CH1211 Geneva, Switzerland. El-Mehdi.Labyb@etu.unige.ch.
Chloé ChrétienDepartment of Cell Physiology and Metabolism, Geneva Medical Centre, CH1211 Geneva, Switzerland. Chloe.chretien21@gmail.com.
Aurélie CaillonLaboratory of Metabolism, Department of Medicine Specialties, Faculty of Medicine, University of Geneva, CH1211 Geneva, Switzerland. Aurelie.Caillon@unige.ch.
Françoise Rohner-JeanrenaudLaboratory of Metabolism, Department of Medicine Specialties, Faculty of Medicine, University of Geneva, CH1211 Geneva, Switzerland. Francoise.Jeanrenaud@unige.ch.
Jordi AltirribaLaboratory of Metabolism, Department of Medicine Specialties, Faculty of Medicine, University of Geneva, CH1211 Geneva, Switzerland. jorge.altirriba@unige.ch.ORCID 0000-0002-8922-2333
University of Geneva · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_160290/1
6 · The paper itself

Abstract

Whereas leptin administration only has a negligible effect on the treatment of obesity, it has been demonstrated that its action can be improved by co-administration of leptin and one of its sensitizers. Considering that oxytocin treatment decreases body weight in obese animals and humans, we investigated the effects of oxytocin and leptin cotreatment. First, lean and diet-induced obese (DIO) mice were treated with oxytocin for 2 weeks and we measured the acute leptin response. Second, DIO mice were treated for 2 weeks with saline, oxytocin (50 μg/day), leptin (20 or 40 µg/day) or oxytocin plus leptin. Oxytocin pre-treatment restored a normal acute leptin response, decreasing food intake and body weight gain. Chronic continuous administration of oxytocin or leptin at 40 µg/day decreased body weight in the presence (leptin) or in the absence (oxytocin) of cumulative differences in food intake. Saline or leptin treatment at 20 µg/day had no impact on body weight. Oxytocin and leptin cotreatments had no additional effects compared with single treatments. These results point to the fact that chronic oxytocin treatment improves the acute, but not the chronic leptin response, suggesting that this treatment could be used to improve the short-term satiety effect of leptin.

Indexed as

Diet, High-FatAnimalsBody WeightEatingLeptinMaleMiceMice, Inbred C57BLMice, ObeseObesityOxytocinLeptinOxytocinfood intakeleptinobesityoxytocin

Identifiers

PMID30587816
PMCPMC6337181
OpenAlexW2905635149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.